Conferences

Catalog

Abstracts

Calendar

Philadelphia Hematologic Malignancies Conference 2026: Advances in Myeloma, Leukemia, Lymphoma & MDS Care

Accreditation: 6.67 Nursing Contact Hours | 6.67 ABIM MOC II | 6.67 AMA PRA Category 1 Credit™ | 6.67 ACPE Pharmacy

Venue: Hilton Philadelphia City Avenue , 4200 City Avenue, Philadelphia, PA, United States

Start Date: September 26, 2026

Overview

Trusted by Thousands of Attendees
Across Our Events

17+

Email if you have questions

Our Agenda

Saturday, September 26th, 2026

All timings are in Eastern Time (EDT, GMT-04:00) time.

07:00 AM - 08:00 AMRegistration, Breakfast, & Exhibits

08:00 AM - 08:10 AMWelcome

08:10 AM - 08:30 AMBinaytara's Efforts in Improving Cancer Care Disparities

08:30 AM - 09:50 AMSession 1: Myeloma

Session Chair: Alfred Garfall, MD

08:30 AM - 08:35 AM

Speaker Introductions

08:35 AM - 08:45 AM

Topic 1: Smoldering Multiple Myeloma: To Treat or Not to Treat? – Sandra Susanibar-Adaniya, MD, MD

08:45 AM - 08:50 AM

Q&A – Sandra Susanibar-Adaniya, MD, MD

08:50 AM - 09:00 AM

Topic 2: Who Should Receive High-Dose Melphalan and Autologous Stem Cell Transplant in 2026? – Asya Varshavsky, MD

09:00 AM - 09:05 AM

Q&A – Asya Varshavsky, MD

09:05 AM - 09:15 AM

Topic 3: Optimal Therapy for First Relapse: CAR-T Cells or Bispecific Antibodies? – Adam Binder, MD

09:15 AM - 09:20 AM

Q&A – Adam Binder, MD

09:20 AM - 09:50 AM

Case-Based Panel Discussion: Standard-Risk Patient with First Relapse

Moderators:

Alfred Garfall, MD

Panelists:

Sandra Susanibar-Adaniya, MD, MD; Asya Varshavsky, MD; Adam Binder, MD

09:50 AM - 10:05 AMBreak & Exhibits

10:05 AM - 11:25 AMSession 2: Acute Leukemias and High Risk MDS

Session Chair: Catherine Lai, MD, MPH

10:05 AM - 10:10 AM

Speaker Introductions

10:10 AM - 10:20 AM

Topic 1: How I Treat Older Patients with Newly Diagnosed AML? – Margaret Kasner, MD

10:20 AM - 10:25 AM

Q&A – Margaret Kasner, MD

10:25 AM - 10:35 AM

Topic 2: The Newest Kid on the Block: Menin Inhibitors – Alexander Perl, MD

10:35 AM - 10:40 AM

Q&A – Alexander Perl, MD

10:40 AM - 10:50 AM

Topic 3: How I treat High-Risk MDS? – Alexander R Vartanov, MD

10:50 AM - 10:55 AM

Q&A – Alexander R Vartanov, MD

10:55 AM - 11:25 AM

Case-Based Panel Discussion: TP53 mutated MDS/AML: To Transplant or not to Transplant? (Case Presenter: Lukas Ronner)

Moderators:

Catherine Lai, MD, MPH

Panelists:

Lukas Ronner, MD; Margaret Kasner, MD; Alexander Perl, MD; Alexander R Vartanov, MD

11:25 AM - 12:45 PMSession 3: MPN/CML/Low Risk MDS

Session Chair: Catherine Lai, MD, MPH

11:25 AM - 11:30 AM

Speaker Introductions

11:30 AM - 11:40 AM

Topic 1: Which JAK Inhibitor do I use as Second Line in MF? – Peter Abdelmessieh, MD

11:40 AM - 11:45 AM

Q&A – Peter Abdelmessieh, MD

11:45 AM - 11:55 AM

Topic 2: How I Treat Transfusion Dependent Low-Intermediate Risk MDS? – Lindsay Wilde, MD

11:55 AM - 12:00 PM

Q&A – Lindsay Wilde, MD

12:00 PM - 12:10 PM

Topic 3: Which TKI Should I use for Newly Diagnosed CML? – Ximena Jordan-Bruno , MD

12:10 PM - 12:15 PM

Q&A – Ximena Jordan-Bruno , MD

12:15 PM - 12:45 PM

Case-Based Panel Discussion: Optimal Treatment Sequencing in Low Risk MDS (Case Presenter: Wyatt McCall)

Moderators:

Catherine Lai, MD, MPH; Wyatt McCall, MD

Panelists:

Peter Abdelmessieh, MD; Lindsay Wilde, MD; Ximena Jordan-Bruno , MD

12:45 PM - 01:45 PMLunch & Exhibits

01:45 PM - 03:20 PMSession 4: Aggressive Lymphomas (B&T)

Session Chair: Marco Ruella, MD

01:45 PM - 01:50 PM

Speaker Introductions

01:50 PM - 02:00 PM

Topic 1: How Frontline Treatment for LBCL is Evolving – Daniel Jeffrey Landsburg, MD

02:00 PM - 02:05 PM

Q&A – Daniel Jeffrey Landsburg, MD

02:05 PM - 02:15 PM

Topic 2: Management of r/r LBCL – Ubaldo E. Martinez Outschoorn, MD

02:15 PM - 02:20 PM

Q&A – Ubaldo E. Martinez Outschoorn, MD

02:20 PM - 02:30 PM

Topic 3: Feasibility of Novel Immunotherapies for NHL in Non-Tertiary Centers

02:30 PM - 02:35 PM

Q&A

02:35 PM - 02:45 PM

Topic 4: The Evolving Landscape of Therapies for T-Cell Lymphomas

02:45 PM - 02:50 PM

Q&A

02:50 PM - 03:20 PM

Case-Based Panel Discussion (Case Presenter: Luca Paruzzo)

Moderators:

Marco Ruella, MD

Panelists:

Daniel Jeffrey Landsburg, MD; Ubaldo E. Martinez Outschoorn, MD; Luca Paruzzo

03:20 PM - 04:40 PMSession 5: CLL and other Lymphomas

Session Chair: Marco Ruella, MD

03:20 PM - 03:25 PM

Speaker Introductions

03:25 PM - 03:35 PM

Topic 1: Are we Curing Follicular Lymphoma? – Stephen J Schuster

03:35 PM - 03:40 PM

Q&A – Stephen J Schuster

03:40 PM - 03:50 PM

Topic 2: How I treat CLL in 2026 – Shazia Nakhoda, MD

03:50 PM - 03:55 PM

Q&A – Shazia Nakhoda, MD

03:55 PM - 04:05 PM

Topic 3: Latest Updates on the Treatment of Hodgkin Lymphoma – Jakub Svoboda, MD

04:05 PM - 04:10 PM

Q&A – Jakub Svoboda, MD

04:10 PM - 04:40 PM

Case-Based Panel Discussion

Moderators:

Marco Ruella, MD

Panelists:

Jakub Svoboda, MD; Shazia Nakhoda, MD

04:40 PM - 04:40 PMAdjourn

About Philadelphia Hematologic Malignancies Conference 2026: Advances in Myeloma, Leukemia, Lymphoma & MDS Care

Overview

Conference program and agenda

Our Agenda

Venue and map

Accreditations and continuing education

Registration and pricing

Exhibitors and sponsorship

Our Agenda